Cargando…
Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication
PURPOSE: To assess the safety and efficacy of one, two, or three trabecular microbypass stents in eyes with primary open-angle glaucoma (OAG) not controlled on ocular hypotensive medication. A total of 119 subjects were followed for 18 months postoperatively. MATERIALS AND METHODS: Subjects with med...
Autores principales: | Katz, L Jay, Erb, Carl, Carceller, Guillamet Amadeu, Fea, Antonio M, Voskanyan, Lilit, Wells, Jeffrey M, Giamporcaro, Jane Ellen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686332/ https://www.ncbi.nlm.nih.gov/pubmed/26715834 http://dx.doi.org/10.2147/OPTH.S96695 |
Ejemplares similares
-
Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes
por: Katz, L Jay, et al.
Publicado: (2018) -
Implantation of two second‐generation trabecular micro‐bypass stents and topical travoprost in open‐angle glaucoma not controlled on two preoperative medications: 18‐month follow‐up
por: Berdahl, John, et al.
Publicado: (2017) -
Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up
por: Chang, David F, et al.
Publicado: (2017) -
Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
por: Lindstrom, Richard, et al.
Publicado: (2016) -
Prospective unmasked randomized evaluation of the iStent inject(®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma
por: Fea, Antonio M, et al.
Publicado: (2014)